Sofinnova Investments, Inc. Mi Nk Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.25 - $3.25 $413,752 - $1.08 Million	-331,002 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.2 - $4.75 $31,893 - $68,860	-14,497 Reduced 4.2%	331,002 $745,000
Q4 2021 Feb 14, 2022	BUY	$4.12 - $20.03 $1.42 Million - $6.92 Million	345,499 New	345,499 $1.54 Million

848K

Ticker INKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,775,100
Market Cap $29M
Description
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.